PureTech Health LLC 3
3 · Vor Biopharma Inc. · Filed Feb 4, 2021
Insider Transaction Report
Form 3
PureTech Health LLC
10% Owner
Holdings
Series A-1 Preferred Stock
→ Common Stock (1,470,588 underlying)Series A-2 Preferred Stock
→ Common Stock (1,595,210 underlying)Series B Preferred Stock
→ Common Stock (141,402 underlying)
Footnotes (1)
- [F1]Each share of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock is convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a 13.6-for-one basis, has no expiration date and will automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering.